Effect of phosphodiesterase inhibitor in patients with sinobronchial syndrome

Effect of phosphodiesterase inhibitor in patients with sinobronchial syndrome - Effect of PDE in SBS

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014193

Enrollment

Registered

2014-06-14

Start date

2014-06-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sinobronchial syndrome

Interventions

Cilostazol Placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with sinobronchilal syndrome

Exclusion criteria

Exclusion criteria: patients with active and uncontrolled infection

Design outcomes

Primary

Measure	Time frame
cough reflex sensitivity to inhaled capsaicin	—

Countries

Japan

Contacts

Public ContactYoshihisa Ishiura

Toyama City Hospital Respiratory Medicine

ishiura@tch.toyama.toyama.jp076-422-1112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026